Admera Health offers fast and scalable COVID19 testing for monitoring active infections to limit additional exposures.
  • Rapid results
  • Accurate results with high sensitivity and specificity
  • Individual and batch results available via a portal
  • Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA)
Inquire About Testing

Admera Health offers fast and scalable COVID19 testing for monitoring active infections to limit additional exposures.
  • Rapid results
  • Accurate results with high sensitivity and specificity
  • Individual and batch results available via a portal
  • Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA)
Inquire About Testing
Type of TestingClarifi COVID-19 Test (PCR Based)
What Does The Test Detect?Active SARS-COV-2 infections, identifying people that should quarantine
Who Can Be Tested?No limitations, but symptomatic patients should reach out to their health care provider
Limit of Detection600 NDU/ml resulting in fewer false negatives
Nucleic acid amplification test-detectable units (NDU)
Collection MethodNon-invasive saliva swab
Price$119 – Individual

For Institutional Surveillance Testing – Contact us

Type of TestingClarifi COVID-19 Test (PCR Based)
What Does The Test Detect?Active SARS-COV-2 infections, identifying people that should quarantine
Who Can Be Tested?No limitations, but symptomatic patients should reach out to their health care provider
Limit of Detection600 NDU/ml resulting in fewer false negatives
Nucleic acid amplification test-detectable units (NDU)
Collection MethodNon-invasive saliva swab
Price$119 – Individual

For Institutional Surveillance Testing – Contact us

Resources

Fact Sheet for Healthcare Providers
Fact Sheet for Patients
Contact Us To Learn More

Admera Health provides high-integrity end-to-end
pharmacogenomics solutions

Pharmacogenomics: Genetics for Smarter Medication Management Against COVID-19

PGxOne™ Plus is a comprehensive pharmacogenomics test that can help select appropriate medications for patients with pre-existing comorbidities (cardiovascular diseases, diabetes, chronic respiratory disease, and others), patients with high-risk genotypes, as well as helping select both medications proposed to treat COVID-19 and those involved with patient supportive care.

Pharmacogenomics Testing: A Proposed Tool to Achieve Better COVID-19 Outcome in Patients with Chronic Disease Who are Prescribed Medications

c9c16f97-ea8a-493b-b36e-6d0307d52859 COVID-19 Testing

COVID-19 Associated Coagulopathies and the Medications with Pharmacogenomics Associations That Are Used to Mitigate Them

926f417a-ed0f-4b8f-8d37-ace2b6d3a939 COVID-19 Testing
Learn More About PGxOne™ Plus Testing

Inquire About Testing

Please fill out the form on the right to learn more about the Clarifi COVID-19 Test offered by Admera Health and/or the PGxOne™ Plus pharmacogenomics test.

Alternatively, you may call us directly at 908-222-0533 followed by Option 3 to speak with a member of the Admera Health Business Development team.

Please fill out the form below to learn more about the Clarifi COVID-19 Test offered by Admera Health and/or the PGxOne™ Plus pharmacogenomics test.

Alternatively, you may call us directly at 908-222-0533 followed by Option 3 to speak with a member of the Admera Health Business Development team.